Project Grant HT94252510994
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $4.5M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Fort Worth, TX 76107, USA
Similar Awards
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $4,000,000.00 in funding to Medcura, Inc. in Riverdale, MD to expand the development and production of a biopolymer powder treatment for noncompressible torso hemorrhage. The research aims to improve health outcomes for military service members and the broader public by advancing this innovative medical technology. The award period extends from Aug 5,...
- The Defense Health Agency awarded a $1,999,583 Project Grant to IRR Inc. under the Military Medical Research and Development program (CFDA 12.420) to conduct an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The performance period for this award runs from July 1, 2025 to June 30, 2027. The purpose of this federal grant is to transform healthcare for military service members, veterans, and the broader public through...
- This $440,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by Baylor College of Medicine in Houston, Texas to develop biopolymers for intestinal healing and immune modulation to treat inflammatory bowel disease. The award has a performance period from January 15, 2025 to January 14, 2027. The Military Medical Research and Development program supports advanced biomedical research to transform...
- The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
- This $2,134,174 Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Metis Foundation supports the development of a "sprayable antimicrobial and regeneration promoting foam scaffold for the treatment of non-healing skin wounds." The grant has an award date of September 1, 2023 and a completion date of August 31, 2027. The Metis Foundation, a non-profit organization that supports innovative medical research and education for...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The U.S. Defense Health Agency has awarded a $3,225,672 Project Grant to Tufts Medical Center Parent, Inc. (TMC), a non-profit academic medical center in Boston, Massachusetts, to support the use of Droplette Micromist Technology Device (DMTD) for deep tissue treatment of pressure ulcers. This 4-year grant, running from July 1, 2023 to June 30, 2027, falls under the Military Medical Research and Development (CFDA 12.420) federal grant program, which aims to transform health care for Service...
- The Defense Health Agency awarded a $293,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Medical Research, Infrastructure And Health Services Fund Of The Tel Aviv Medical Center in Israel. The grant, awarded on April 1, 2025, supports a research project investigating "Clinical Variation in Epidermolysis Bullosa: A New Layer of Complexity and a New Opportunity for Understanding Wound Healing." This specialized medical research project...
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
- This $487,407 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by Factor Bioscience Inc. in East Cambridge, MA. The objective is to develop iPSC-derived mesenchymal stromal cells expressing a novel TNF inhibitor for the treatment of rheumatoid arthritis. This 1-year project, running from August 1, 2025 to July 31, 2026, aims to advance innovative biomedical solutions to address critical health...